Bristol Myers (BMY) r&d spend was $10.0B in FY2025 (-11% YoY). The tables below show the complete quarterly and annual r&d spend history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual R&D Spend
Fiscal Year
R&D Spend
YoY
2025
$10.0B
-11%
2024
$11.2B
+20%
2023
$9.3B
-2%
2022
$9.5B
-7%
2021
$10.2B
+1%
2020
$10.0B
+63%
2019
$6.1B
-3%
2018
$6.3B
-2%
2017
$6.5B
+29%
2016
$5.0B
-15%
2015
$5.9B
+31%
2014
$4.5B
+22%
2013
$3.7B
-4%
2012
$3.9B
+2%
2011
$3.8B
+8%
2010
$3.6B
-2%
2009
$3.6B
+4%
2008
$3.5B
+11%
2007
$3.2B
Recent Quarterly R&D Spend
Quarter
R&D Spend
Q2 2026
$3.0B
Q1 2026
$2.6B
Q4 2025
$2.6B
Q3 2025
$2.5B
Q2 2025
$2.6B
Q1 2025
$2.3B
Q4 2024
$3.2B
Q3 2024
$2.4B
Q2 2024
$2.9B
Q1 2024
$2.7B
Q4 2023
$2.5B
Q3 2023
$2.2B
Source: BMY on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.